Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024424 · ClinicalTrials.gov registry record · NA
Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03024424: Completed NA study, sponsored by University of Utah.
NCT03024424 is a NA study that has completed, run by University of Utah. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03024424, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degeneration (AMD), and to assess the impact of presymptomatic genetic testing for choroidal neovascularization (CNV).
Primary Outcome
Carotenoid levels in the skin are measured non-invasively at baseline and again at 12 months. Carotenoid levels are a biomarker of fruit and vegetable intake.
Interventions
- BEHAVIORAL Early disclosure
- BEHAVIORAL Late disclosure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-08-10 |
| Phase | NA |
What the finished NCT03024424 record still lists
NCT03024424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Early disclosure is the first listed.
NCT03024424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03024424 about?
NCT03024424 is a clinical study titled "Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD". The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degenerat...
What is the current status of trial NCT03024424?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-03. Estimated completion is 2017-08-10.
What interventions are being tested in trial NCT03024424?
The interventions under investigation include: Early disclosure (BEHAVIORAL), Late disclosure (BEHAVIORAL).
Who is sponsoring clinical trial NCT03024424?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03024424's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia